Established in the San Francisco Bay Area in 2024 by Bill Mallet, Pedalion Bio is a consulting firm focusing on early-stage biopharma. I advise emerging companies on pipeline strategy, critical-path activities, selection of CROs and advisors, and resource allocation. I also support investors in evaluation of start-up companies and new ventures. Pedalion Bio specializes in therapeutic antibodies and antibody conjugates for cancer, fibrosis, and I&I diseases.